Lupus anticoagulant testing is a clotting-based laboratory investigation, not a test that diagnoses lupus. The name is confusing: lupus anticoagulants are antiphospholipid antibodies that can interfere with phospholipid-dependent clotting tests in the laboratory and are associated with antiphospholipid syndrome (APS) in the appropriate clinical setting. Testing may be considered after unexplained thrombosis, recurrent pregnancy loss or investigation of a prolonged APTT. Results usually require a panel and careful interpretation rather than one simple positive-or-negative test.
What Is a Lupus Anticoagulant?
A lupus anticoagulant, often abbreviated LA, is an autoantibody that interferes with phospholipid-dependent coagulation reactions in laboratory testing.
Despite the word “anticoagulant”, the clinical association is not simply a tendency to bleed. Persistent lupus anticoagulant can be associated with increased thrombotic risk in antiphospholipid syndrome.
The name is historical and can create two common misunderstandings:
- It is not a specific diagnostic test for systemic lupus erythematosus.
- Its laboratory anticoagulant effect does not mean the person is necessarily clinically anticoagulated.
Some people with lupus can have antiphospholipid antibodies, but these antibodies can also occur in people who do not have lupus.
For the broader autoimmune context, see lupus blood tests explained.
What Is Antiphospholipid Syndrome?
Antiphospholipid syndrome is an acquired autoimmune condition associated with thrombosis and/or particular pregnancy complications in people with persistent antiphospholipid antibodies.
NHS guidance states that testing may be offered where someone has had an unexplained blood clot or recurrent miscarriages, and confirmation requires repeat blood testing separated in time.
The main laboratory antibody groups used in APS assessment include:
- lupus anticoagulant
- anticardiolipin antibodies
- anti-beta-2 glycoprotein I antibodies
These tests are related but not interchangeable.
A person can be positive for one, two or all three antibody groups. Laboratory positivity by itself is not equivalent to an APS diagnosis; clinical criteria and persistence matter.
Why Is Lupus Anticoagulant Testing Ordered?
Testing is targeted rather than a routine screening test for everyone.
Possible indications include:
Unexplained thrombosis
Testing may be considered when a venous or arterial thrombotic event occurs without an obvious explanation, particularly where the clinical circumstances make APS relevant.
Recurrent pregnancy loss
APS is one of the conditions considered in selected investigations of recurrent miscarriage or pregnancy morbidity.
Prolonged APTT
Lupus anticoagulants can prolong phospholipid-dependent clotting tests such as the APTT in vitro. When an unexplained prolonged APTT is found, LA testing may form part of the laboratory investigation.
Selected autoimmune or specialist assessment
Some NHS laboratories list specialist connective-tissue-disease assessment among indications, depending on clinical review.
The test should not be ordered simply because someone has a positive ANA or because “lupus” appears in the name.
How Does Lupus Anticoagulant Testing Work?
There is no single universal “lupus anticoagulant concentration” test.
Laboratories generally use a sequence of phospholipid-dependent clotting tests to look for the characteristic inhibitor pattern.
The process may include:
- a screening test that is sensitive to lupus anticoagulant
- additional testing to assess whether the prolonged clotting behaviour behaves like an inhibitor
- a confirmatory test using increased phospholipid to see whether the abnormality corrects in a way supporting phospholipid dependence
Common laboratory methods include the dilute Russell’s viper venom time (dRVVT) and LA-sensitive APTT-based methods.
Exact algorithms vary by laboratory and reagent system.
This is why a patient report may contain several ratios or comments rather than one simple number.
What Is the Relationship Between Lupus Anticoagulant and APTT?
The activated partial thromboplastin time (APTT) measures clot formation through part of the coagulation system.
A lupus anticoagulant can prolong the APTT because the assay relies on phospholipids. However:
- not every lupus anticoagulant prolongs every APTT reagent
- a prolonged APTT has many other possible causes
- a normal APTT does not universally exclude lupus anticoagulant
- anticoagulant medicines can complicate interpretation
Therefore, an abnormal APTT is a starting clue rather than a diagnosis.
See pt inr aptt explained and coagulation tests explained for the wider clotting-test context.
Why Mixing and Confirmatory Steps Matter
When a clotting time is prolonged, laboratories may need to distinguish a factor deficiency from an inhibitor effect.
A mixing study combines patient plasma with normal plasma. In simplified terms, a deficiency may show more correction because the normal plasma supplies the missing factor, while an inhibitor may continue to interfere with clotting.
Lupus anticoagulant investigation then uses phospholipid-dependent confirmatory logic.
This explanation is intentionally simplified. Laboratory interpretation depends on the exact reagents, ratios, local cut-offs and anticoagulant status.
What Do “Detected”, “Not Detected” and “Indeterminate” Mean?
Some NHS laboratories report lupus anticoagulant as:
- detected
- not detected
- indeterminate
“Detected” means the laboratory pattern is consistent with a lupus anticoagulant under that testing algorithm. It does not by itself establish APS.
“Not detected” means the laboratory did not find the defined pattern in that sample under the conditions of testing.
“Indeterminate” means the pattern cannot be classified confidently, which may prompt repeat testing or specialist review.
University Hospitals of North Midlands notes that a detected lupus anticoagulant should be confirmed by repeat testing after at least 12 weeks in the appropriate context.
Why Repeat Testing Is Important
Antiphospholipid antibodies can be transient, particularly around infections or acute illness.
APS classification therefore requires persistence rather than a single isolated positive result.
The NHS states that two blood tests separated by about three months are needed to confirm the antibody persistence used in diagnosis of APS.
This protects against over-interpreting a temporary laboratory finding.
How Do Anticoagulant Medicines Affect Testing?
Anticoagulants are a major source of complexity.
Warfarin, heparins and direct oral anticoagulants can interfere with clot-based assays and may produce misleading patterns. NHS laboratory guidance may therefore specify circumstances when LA testing should be avoided, delayed or discussed with specialist haematology.
A person should not stop anticoagulant medication simply to obtain a cleaner laboratory result without medical direction.
Laboratories rely on accurate medication information so they can interpret results appropriately and choose suitable strategies.
Lupus Anticoagulant vs Anticardiolipin Antibodies
Lupus anticoagulant is detected using functional clotting assays.
Anticardiolipin and anti-beta-2 glycoprotein I antibodies are usually measured using solid-phase immunoassays.
They look for related antiphospholipid antibody phenomena through different laboratory methods.
That is why APS assessment often includes all three groups rather than treating them as duplicate tests.
Cambridge University Hospitals notes that anticardiolipin antibodies are not diagnostic on their own and that lupus anticoagulant should also be assessed in the appropriate APS work-up.
Does Lupus Anticoagulant Mean a Person Has Lupus?
No.
This is the single most important naming issue.
Lupus anticoagulant was historically identified in association with lupus, but it is not specific to lupus and can occur in APS with or without systemic lupus erythematosus.
Conversely, having lupus does not automatically mean lupus anticoagulant will be present.
A lupus work-up may involve ANA and more specific autoantibodies, while lupus anticoagulant testing belongs primarily to the coagulation/APS pathway.
What Can Interfere With the Result?
Potential influences include:
- anticoagulant treatment
- an acute thrombotic event
- acute illness or inflammation
- timing of testing
- sample quality
- pre-analytical handling
- reagent sensitivity
This is one reason specialist laboratories provide comments and sometimes recommend repeat testing.
What Happens After a Positive Result?
The next step depends on why testing was performed and whether other antiphospholipid antibodies are present.
Clinicians may review:
- the history of thrombosis
- pregnancy history
- anticardiolipin results
- anti-beta-2 glycoprotein I results
- whether the LA result persists after at least 12 weeks
- current medicines
- other thrombosis risk factors
A positive laboratory result should not be converted into an online diagnosis.
Key Points
- Lupus anticoagulant testing is a clotting-test panel, not a lupus diagnostic test.
- Lupus anticoagulants are associated with APS in the appropriate clinical context.
- Testing can involve dRVVT, APTT-based assays and confirmatory steps.
- Anticardiolipin and anti-beta-2 glycoprotein I antibodies are separate parts of APS testing.
- Anticoagulant medicines can interfere with results.
- Persistent positivity matters; transient antibodies can occur.
- A positive LA result alone is not the same as a diagnosis of APS.
References
- NHS. Antiphospholipid syndrome (APS). https://www.nhs.uk/conditions/antiphospholipid-syndrome/
- University Hospitals of North Midlands NHS Trust. Lupus Anticoagulant. https://www.uhnm.nhs.uk/our-services/pathology/tests/lupus-anticoagulant/
- MedlinePlus. Antiphospholipid syndrome – APS. https://medlineplus.gov/ency/article/000547.htm
- MedlinePlus. Partial Thromboplastin Time (PTT) Test. https://medlineplus.gov/lab-tests/partial-thromboplastin-time-ptt-test/
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional about your results.
Lupus Blood Tests Explained: ANA and Beyond
Coagulation Tests Explained: PT, INR, APTT, and D-Dimer
Frequently Asked Questions
Is lupus anticoagulant testing a test for lupus?
No. Lupus anticoagulant testing is mainly part of an antiphospholipid syndrome and clotting investigation. The antibody can occur with or without systemic lupus erythematosus.
Why can lupus anticoagulant prolong the APTT?
The antibody can interfere with phospholipid-dependent reactions used by the laboratory APTT assay, making clotting appear prolonged in vitro. This laboratory effect does not translate directly into a simple bleeding tendency.
What other tests are done with lupus anticoagulant?
APS testing commonly includes anticardiolipin antibodies and anti-beta-2 glycoprotein I antibodies in addition to clot-based lupus anticoagulant assays.
Why is lupus anticoagulant testing repeated after 12 weeks?
Antiphospholipid antibodies can be transient. Demonstrating persistence on repeat testing separated by at least 12 weeks is important when APS is being assessed.
Can anticoagulant medicines affect lupus anticoagulant testing?
Yes. Warfarin, heparins and direct oral anticoagulants can interfere with clot-based assays. Testing strategy may therefore require specialist laboratory and clinical planning.
Does a positive lupus anticoagulant result mean antiphospholipid syndrome?
No. APS assessment requires the laboratory findings to be interpreted with the relevant clinical history and persistence of antiphospholipid antibodies. A single positive result is not sufficient on its own.